ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

CU

Copenhagen University Hospital – Herlev at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Copenhagen University Hospital – Herlev takes part in 9 sessions at ESMO 2026 in Madrid. Its work at the meeting spans several cancer types, with a focus on immunotherapy and patient outcomes. It examines survival after stopping immune checkpoint treatment in melanoma and care approaches for pancreatic cancer.

OrganizationESMO 2026 Attendance
CU
Copenhagen University Hospital – Herlev
Herlev, Denmark
Cancer centre & hospital
Public university hospital in Herlev, near Copenhagen, Denmark, home to a national centre for cancer immune therapy.
Poster
Fri Oct 23
13:00–15:00
Talk
Sat Oct 24
11:44–11:51
Table 3
Mentor the Mentor session
Poster
Sat Oct 24
12:00–12:45
Impact on survival of early discontinuation of immune checkpoint inhibitors after objective response in melanoma
Saturday Poster Display session 4
Melanoma & skin cancers
Poster
Sat Oct 24
12:00–12:45
Abstract
Sat Oct 24
16:42–16:54
Invited Discussant LBA1
Presidential Symposium I
Lung & thoracic cancersMelanoma & skin cancersGenitourinary cancers
Poster
Sun Oct 25
12:00–12:45
Early specialized palliative care in advanced pancreatic cancer (EarlyCarePan): A nationwide Danish randomized trial
Sunday Poster Display session 4
Gastrointestinal cancersNursing & supportive care
Poster
Sun Oct 25
12:00–12:45
Real world outcomes in small bowel adenocarcinoma patients from eastern Denmark
Sunday Poster Display session 5
Gastrointestinal cancersSarcoma, CNS, head & neck and rare cancers
Talk
Sun Oct 25
14:45–15:05
Acute and late toxicities of TILs and TCR therapy in solid tumours
Toxicities of immunotherapies beyond immune checkpoints
Nursing & supportive care
Chair
Sun Oct 25
14:45–16:15
Toxicities of immunotherapies beyond immune checkpoints
with Vall d'Hebron Institute of Oncology (VHIO)
Nursing & supportive care
Poster
Mon Oct 26
12:00–12:45
Association between first-line intensification strategies and progression after initial benefit in EGFRm NSCLC
Monday Poster Display session 4
Lung & thoracic cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Copenhagen University Hospital – Herlev

Tell us what you sell and we’ll find the people at Copenhagen University Hospital – Herlev most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction